focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied Materials
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied MaterialsView Video
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to mining
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to miningView Video

Latest Share Chat

Director dealings: IPF non-exec picks up shares, Hutchmed China director linked to sale

Thu, 14th Sep 2023 13:09

(Sharecast News) - International Personal Finance was among the companies on the list of director purchases on Thursday after a non-executive director spent more than £18k on shares.

The company said Deborah Davis picked up 15,000 shares on 13 September in a single transaction on the London Stock Exchange.

It said Davis paid 122.5p for each share, valuing the transaction at £18,375.00.

On the selling side of things was Hutchmed China after it disclosed that the spouse of an independent non-executive director had offloaded a tranche of shares.

The firm said Debbie Sue Chung, the spouse of director Graeme Jack, sold 3,000 American depositary shares on 12 September in a single transaction on the Nasdaq.

Chung sold the shares for $14.70 apiece, giving the sale a total value of $44,100.

At 1437 BST, shares in International Personal Finance were down 0.4% at 124p, while those in Hutchmed China were 1.71% firmer at 237.5p.

Reporting by Josh White for Sharecast.com.

Top Director Buys

Jardine Matheson Holdings Ltd (singapore Reg) (JAR)

Director name: Pang,Yiu Kai

Amount purchased: 30,000 @ $46.75

Value: $1,402,500.00

Ninety One (N91)

Director name: Toit,Hendrik du

Amount purchased: 175,000 @ 167.00p

Value: £292,249.99

Fevertree Drinks (FEVR)

Director name: Havelock,Kevin

Amount purchased: 1,589 @ 1,258.56p

Value: £19,998.52

Fevertree Drinks (FEVR)

Director name: Havelock,Kevin

Amount purchased: 1,583 @ 1,263.33p

Value: £19,998.51

Fevertree Drinks (FEVR)

Director name: Havelock,Kevin

Amount purchased: 1,574 @ 1,270.55p

Value: £19,998.46

Fevertree Drinks (FEVR)

Director name: Havelock,Kevin

Amount purchased: 1,577 @ 1,268.11p

Value: £19,998.09

Fevertree Drinks (FEVR)

Director name: Havelock,Kevin

Amount purchased: 1,564 @ 1,278.31p

Value: £19,992.77

Fevertree Drinks (FEVR)

Director name: Havelock,Kevin

Amount purchased: 1,582 @ 1,263.63p

Value: £19,990.63

Ninety One (N91)

Director name: McFarland,Kim Mary

Amount purchased: 11,392 @ 167.00p

Value: £19,024.64

International Personal Finance (IPF)

Director name: Davis,Deborah

Amount purchased: 15,000 @ 122.50p

Value: £18,375.00

Fevertree Drinks (FEVR)

Director name: Havelock,Kevin

Amount purchased: 774 @ 1,290.90p

Value: £9,991.57

Caledonia Mining Corporation (di) (CMCL)

Director name: Holtzhausen ,Johan

Amount purchased: 1,200 @ 795.00p

Value: £9,540.00

Mitie Group (MTO)

Director name: Bentley,Phillip

Amount purchased: 145 @ 104.00p

Value: £150.80

Mitie Group (MTO)

Director name: Bentley,Phillip

Amount purchased: 73 @ n/a

Value: n/a

Top Director Sells

Ashmore Group (ASHM)

Director name: Shippey,Tom

Amount sold: 45,821 @ 191.65p

Value: £87,815.95

Hutchmed (china) Limited (HCM)

Director name: Jack,Graeme Allan

Amount sold: 15,000 @ $2.94

Value: $36,365.14

Related Shares

More News
14 May 2024 14:33

Hutchmed announces trials of HMPL-306 and Surufatinib cancer therapies

(Alliance News) - Hutchmed (China) Ltd on Tuesday announced upcoming trials for two of its pipeline cancer treatments, both of which it believes could...

14 May 2024 11:42

Hutchmed China launches two cancer treatment trials

(Sharecast News) - Hutchmed China announced the start of two significant clinical trials on Tuesday, aimed at addressing critical unmet needs in cance...

3 May 2024 13:37

UK shareholder meetings calendar - next 7 days

26 Apr 2024 16:09

Hutchmed notes CHMP's positive opinion for fruiquintinib approval

(Alliance News) - Hutchmed (China) Ltd on Friday said that its partner Takeda Pharmaceutical Co Ltd has been notified that the Committee for Medicinal...

5 Apr 2024 11:54

Hutchmed China to make several presentations at cancer research meeting

(Sharecast News) - Hutchmed China announced the upcoming presentation of new and updated data from various studies featuring compounds it had discover...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.